載入...
(18)F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma
Liver transplantation (LT) has become standard of care in patients with non-resectable early stage hepatocellular carcinoma (HCC) in liver cirrhosis. Currently, patient selection for LT is strictly based on tumor size and number, provided by the Milan criteria. This may, however, exclude patients wi...
Na minha lista:
| 發表在: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
XIA & HE Publishing Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606969/ https://ncbi.nlm.nih.gov/pubmed/28936404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2017.00014 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|